Hill-Rom Holdings Inc (NYSE:HRC) has been assigned an average rating of “Buy” from the nine research firms that are presently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $87.29.

Several equities analysts have issued reports on HRC shares. Zacks Investment Research cut Hill-Rom Holdings from a “hold” rating to a “sell” rating in a research report on Wednesday, August 2nd. BidaskClub cut Hill-Rom Holdings from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 24th. Needham & Company LLC dropped their target price on Hill-Rom Holdings from $95.00 to $93.00 and set a “buy” rating on the stock in a research report on Friday, July 28th. Cantor Fitzgerald set a $86.00 target price on Hill-Rom Holdings and gave the stock a “hold” rating in a research report on Friday, July 28th. Finally, Stifel Nicolaus restated a “buy” rating and issued a $84.00 price target on shares of Hill-Rom Holdings in a report on Sunday, July 30th.

In related news, SVP Andreas G. Frank sold 6,870 shares of the company’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $77.48, for a total value of $532,287.60. Following the sale, the senior vice president now owns 16,701 shares of the company’s stock, valued at approximately $1,293,993.48. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, SVP Andreas G. Frank sold 3,940 shares of the company’s stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $77.84, for a total value of $306,689.60. Following the completion of the sale, the senior vice president now directly owns 16,701 shares in the company, valued at approximately $1,300,005.84. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.

A number of hedge funds have recently bought and sold shares of HRC. Independent Portfolio Consultants Inc. lifted its stake in Hill-Rom Holdings by 171.5% in the 2nd quarter. Independent Portfolio Consultants Inc. now owns 1,344 shares of the medical technology company’s stock valued at $107,000 after buying an additional 849 shares in the last quarter. Seven Eight Capital LP purchased a new stake in Hill-Rom Holdings in the 2nd quarter valued at approximately $127,000. Acrospire Investment Management LLC lifted its stake in Hill-Rom Holdings by 43.4% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,983 shares of the medical technology company’s stock valued at $158,000 after buying an additional 600 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Hill-Rom Holdings by 10.2% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,201 shares of the medical technology company’s stock valued at $175,000 after buying an additional 204 shares in the last quarter. Finally, Citigroup Inc. lifted its stake in Hill-Rom Holdings by 21.1% in the 2nd quarter. Citigroup Inc. now owns 2,483 shares of the medical technology company’s stock valued at $198,000 after buying an additional 433 shares in the last quarter. 82.44% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: This piece of content was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright laws. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2017/11/02/hill-rom-holdings-inc-hrc-receives-consensus-recommendation-of-buy-from-analysts.html.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Analyst Recommendations for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.